The yield on the benchmark 10-year Treasury note started the week on a tear, jumping to 2.99 percent and toying with the key 3 percent level that could trigger a reaction across global financial markets.
According to sources, China is getting close to announcing a revised National Reimbursement Drug List (NRDL), the group of drugs covered by China’s national insurance plan. There will be 300 additions, 130 of which will be chemical drugs. The rest will be traditional Chinese medicines. This is the first update of the NRDL since 2009. Last May, China negotiated....More>>>
This article is reprinted by permission from NextAvenue.org.
To the question Does working past the traditional retirement age keep you mentally sharp? the answer was a qualified yes among several scholars attending the recent 2017 Age Boom Academy at Columbia University in early June. (Ill get to the caveats later.)
Intriguing evidence that work helps boost cognitive health among older....More>>>
When Congress changed Social Security spousal benefit provisions in November 2015, it grandfathered anyone 62 or over 62 as of January 1, 2016. The grandfathering permitted anyone meeting this birth deadline to file just for a spousal benefit starting at full retirement age, while waiting till 70 to collect their own retirement benefit, when it would start at its largest possible....More>>>
GrubHub, Inc. (NYSE:GRUB) is an over-hyped growth stock whose growth prospects are misunderstood by the market. Despite big growth as a first-mover to the large online food and delivery service market, GRUB’s business model is defenseless despite its perceived “network effect.” GRUB’s projected growth runway will be eaten up by competing products from goliaths:....More>>>
I don’t know if the bull market in bonds is over or not, and nor do I care. I’m not in the business of playing Captain Prediction. I trade the markets that are in front of me, using my data-dependent 3G investing framework, explains Landon Whaley, editor of The Whaley Report.
As we begin 2017, all three gravities — fundamental, quantitative, and behavioral — are....More>>>
There are numerous trading techniques to consider for each and every options trade, so Fred Oltarsh at Options Strategy Network details five of the ones he considers extremely vital for trying to put the percentages in the trader’s favor.
The key to trading options contracts successfully (individual stocks and futures as well) is to put the percentages in your favor. This involves....More>>>
The stock of the Deckers Outdoor Corporation (NASDAQ:DECK) is best positioned to return over 22% to its shareholders in the short-term investment horizon, although long-term prospects are much brighter based on the improving company’s business prospects. Despite its excellent performance in the last one year (over 30% run-up), DECK is still undervalued and offers a....More>>>
AMGN,AVEO,BGNE,BMY,CELG,Deals and Financings,FPRX,TCON,TRXC,VTVT,ZLAB,
Nanjing Legend Biotech received a $350 million upfront payment from Janssen Biotech, which will form a global partnership with Legend for its highly effective CAR-T candidate. In June, Legend, which was not previously well known, surprised the annual ASCO meeting with stunningly positive results
Rising tensions with North Korea and the recent threat to Florida from Hurricane Irma contributed to the slight decline in the S&P 500 Index last week. While news was otherwise slow, a handful of leading dividend stocks rewarded shareholders with news of higher divide
Debenhams (OTC:DBHSF) (OTCPK:DBHSY) faces a number of headwinds that would be difficult to tackle if only one of them were present. Some of them are exacerbated by the potential problems caused by Brexit, but even if Brexit is miraculously, painlessly resolved, there are enough problems in the re
Tesaro's (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTes
With the broader markets hovering around their all-time highs at the moment, the idea of buying individual stocks that are at or close to their 52-week highs may not sound all that appealing. Stocks with the richest valuations, after all, are likely to be the hardest hit in the event of a marketwid